Total Payments
$2,284
2024 Payments
$13.77
Companies
25
Transactions
167
Medicare Patients
21,769
Medicare Billing
$2.4M
Payment Breakdown by Category
Food & Beverage$2,255 (98.7%)
Education$29.27 (1.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,255 | 165 | 98.7% |
| Education | $29.27 | 2 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie Inc. | $753.12 | 69 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $372.57 | 28 | $0 (2023) |
| Janssen Biotech, Inc. | $161.27 | 9 | $0 (2022) |
| PFIZER INC. | $140.68 | 10 | $0 (2023) |
| Lilly USA, LLC | $111.29 | 7 | $0 (2020) |
| GENZYME CORPORATION | $108.27 | 6 | $0 (2021) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $88.41 | 5 | $0 (2020) |
| Regeneron Healthcare Solutions, Inc. | $87.79 | 3 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $82.23 | 5 | $0 (2024) |
| Galderma Laboratories, L.P. | $45.47 | 3 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $13.77 | 1 | Boehringer Ingelheim Pharmaceuticals, Inc. ($13.77) |
| 2023 | $291.90 | 17 | AbbVie Inc. ($177.39) |
| 2022 | $218.97 | 30 | ABBVIE INC. ($150.52) |
| 2021 | $197.31 | 23 | AbbVie Inc. ($158.53) |
| 2020 | $151.81 | 8 | Novartis Pharmaceuticals Corporation ($46.95) |
| 2019 | $412.66 | 24 | AbbVie, Inc. ($154.25) |
| 2018 | $480.01 | 26 | Janssen Biotech, Inc. ($83.36) |
| 2017 | $517.90 | 38 | Novartis Pharmaceuticals Corporation ($214.10) |
All Payment Transactions
167 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $13.77 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $4.49 | General |
| Category: IMMUNOLOGY | ||||||
| 08/28/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: IMMUNOLOGY | ||||||
| 07/27/2023 | Novartis Pharmaceuticals Corporation | XOLAIR (Drug) | Food and Beverage | In-kind items and services | $12.71 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 07/25/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $6.23 | General |
| Category: IMMUNOLOGY | ||||||
| 07/17/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $20.57 | General |
| Category: IMMUNOLOGY | ||||||
| 07/11/2023 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $5.03 | General |
| Category: IMMUNOLOGY | ||||||
| 06/01/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $11.18 | General |
| Category: IMMUNOLOGY | ||||||
| 04/26/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $5.93 | General |
| Category: IMMUNOLOGY | ||||||
| 04/12/2023 | PFIZER INC. | EUCRISA (Drug), CIBINQO | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: DERMATOLOGY | ||||||
| 03/31/2023 | PFIZER INC. | CIBINQO (Drug) | Education | In-kind items and services | $15.27 | General |
| Category: Inflammation & Immunology | ||||||
| 03/29/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: IMMUNOLOGY | ||||||
| 03/21/2023 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $5.34 | General |
| Category: IMMUNOLOGY | ||||||
| 02/28/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $5.71 | General |
| Category: IMMUNOLOGY | ||||||
| 02/28/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $0.95 | General |
| Category: IMMUNOLOGY | ||||||
| 02/13/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: IMMUNOLOGY | ||||||
| 02/02/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: Dermatology | ||||||
| 01/10/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $7.53 | General |
| Category: IMMUNOLOGY | ||||||
| 12/19/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $12.96 | General |
| Category: IMMUNOLOGY | ||||||
| 12/14/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $6.32 | General |
| Category: IMMUNOLOGY | ||||||
| 12/07/2022 | Dermavant Sciences, Inc. | VTAMA (Drug) | Education | In-kind items and services | $14.00 | General |
| Category: DERMATOLOGY | ||||||
| 11/09/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $6.54 | General |
| Category: IMMUNOLOGY | ||||||
| 11/01/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $4.19 | General |
| Category: IMMUNOLOGY | ||||||
| 10/20/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $5.17 | General |
| Category: IMMUNOLOGY | ||||||
| 10/10/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $4.20 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 28 | 5,344 | 11,019 | $1.1M | $599,064 |
| 2022 | 26 | 5,536 | 11,838 | $1.2M | $616,582 |
| 2021 | 30 | 5,864 | 12,591 | $1.2M | $651,490 |
| 2020 | 29 | 5,025 | 11,147 | $1.0M | $493,593 |
Total Patients
21,769
Total Services
46,595
Medicare Billing
$2.4M
Procedure Codes
113
All Medicare Procedures & Services
113 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 600 | 842 | $126,300 | $91,890 | 72.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 684 | 1,109 | $121,990 | $85,079 | 69.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 577 | 710 | $110,050 | $72,050 | 65.5% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 146 | 215 | $86,000 | $66,688 | 77.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 451 | 630 | $91,350 | $50,059 | 54.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 698 | 1,114 | $111,400 | $49,716 | 44.6% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 537 | 1,196 | $161,460 | $40,715 | 25.2% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 554 | 3,753 | $56,295 | $26,155 | 46.5% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 102 | 132 | $42,900 | $15,983 | 37.3% |
| 12052 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | Office | 2023 | 43 | 49 | $20,090 | $15,814 | 78.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 178 | 242 | $19,360 | $12,311 | 63.6% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 62 | 74 | $26,640 | $10,008 | 37.6% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 43 | 51 | $15,045 | $8,088 | 53.8% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 66 | 72 | $13,680 | $8,021 | 58.6% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 93 | 155 | $12,400 | $7,828 | 63.1% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 154 | 154 | $14,630 | $7,420 | 50.7% |
| 11642 | Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 51 | 54 | $20,250 | $7,201 | 35.6% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 42 | 43 | $7,955 | $5,254 | 66.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 48 | 48 | $6,960 | $3,864 | 55.5% |
| 11042 | Removal of skin and tissue, 20.0 sq cm or less | Office | 2023 | 15 | 27 | $4,590 | $3,599 | 78.4% |
| 12042 | Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm | Office | 2023 | 11 | 11 | $4,400 | $3,288 | 74.7% |
| 69100 | Biopsy of ear | Office | 2023 | 33 | 36 | $7,200 | $2,680 | 37.2% |
| 11622 | Removal of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 15 | 16 | $5,200 | $2,060 | 39.6% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 34 | 38 | $2,850 | $1,428 | 50.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 19 | 94 | $7,050 | $1,290 | 18.3% |
About Dr. Stephen Dalton, M.D
Dr. Stephen Dalton, M.D is a Dermatology healthcare provider based in Novato, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2005. The National Provider Identifier (NPI) number assigned to this provider is 1053318824.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Dalton, M.D has received a total of $2,284 in payments from pharmaceutical and medical device companies, with $13.77 received in 2024. These payments were reported across 167 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($2,255).
As a Medicare-enrolled provider, Dalton has provided services to 21,769 Medicare beneficiaries, totaling 46,595 services with total Medicare billing of $2.4M. Data is available for 4 years (2020–2023), covering 113 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Novato, CA
- Active Since 07/07/2005
- Last Updated 10/09/2008
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1053318824
Products in Payments
- SKYRIZI (Biological) $398.65
- COSENTYX (Biological) $282.99
- Skyrizi (Biological) $130.99
- EUCRISA (Drug) $125.41
- Humira (Biological) $113.01
- Tremfya (Drug) $111.81
- TALTZ (Drug) $111.29
- SPEVIGO (Drug) $82.23
- DUPIXENT (Drug) $80.80
- RINVOQ (Biological) $77.98
- DUPIXENT DUPILUMAB INJECTION (Biological) $66.85
- XOLAIR (Biological) $61.63
- Otezla (Drug) $47.13
- DORYX (Drug) $37.71
- Finacea (Drug) $36.90
- REMICADE (Biological) $34.71
- DUPIXENT (Biological) $27.47
- Avar (Drug) $26.19
- HUMIRA (Biological) $25.40
- PRALUENT ALIROCUMAB INJECTION (Biological) $20.94
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.